Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-12-063571
Filing Date
2012-11-16
Accepted
2012-11-16 17:19:22
Documents
7
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-Q v328282_10qa.htm 10-Q/A 21691
  Complete submission text file 0001144204-12-063571.txt   4684852

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT mslp-20120930.xml EX-101.INS 646856
3 XBRL TAXONOMY EXTENSION SCHEMA mslp-20120930.xsd EX-101.SCH 75380
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mslp-20120930_cal.xml EX-101.CAL 40775
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mslp-20120930_def.xml EX-101.DEF 263182
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mslp-20120930_lab.xml EX-101.LAB 453302
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mslp-20120930_pre.xml EX-101.PRE 351447
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

EIN.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-53166 | Film No.: 121212573
SIC: 2834 Pharmaceutical Preparations